Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Nurix Therapeutics (NRIX) Insider Trading & Ownership

Nurix Therapeutics logo
$26.30 +1.37 (+5.48%)
As of 03:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Nurix Therapeutics (NASDAQ:NRIX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.70%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$1.83M
Get NRIX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nurix Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NRIX Insider Buying and Selling by Quarter

Nurix Therapeutics Insider and Congressional Trades History

Transaction Date
0 Results
Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/15/2026Sell1,452$25.00$36,300.00  
10/14/2026Sell22,583$23.40$528,442.20  
9/1/2026Sell1,452$25.47$36,982.44  
8/5/2026Sell4,356$25.00$108,900.00  
8/4/2026Sell4,111$24.36$100,143.96  
8/4/2026Sell4,761$24.36$115,977.96  
7/30/2026Sell3,847$23.38$89,942.86  
7/30/2026Sell2,845$23.38$66,516.10  
6/25/2026Sell5,394$20.00$107,880.00  
5/5/2026Sell14,055$16.60$233,313.00  
4/30/2026Sell3,214$16.65$53,513.10  
4/30/2026Sell2,388$16.65$39,760.20  
1/30/2026Sell4,895$16.60$81,257.00  
1/30/2026Sell3,661$16.60$60,772.60  
11/3/2025Sell6,284$12.56$78,927.04  
10/30/2025Sell4,087$12.80$52,313.60  
10/30/2025Sell3,130$12.80$40,064.00  
(Data available from 1/1/2013 forward)

NRIX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Nurix Therapeutics includes Christine Ring, Gwenn Hansen, Houte Hans Van, and Julia P Gregory. Learn more on insiders at NRIX.

6.70% of Nurix Therapeutics stock is owned by insiders. Learn more on NRIX's insider holdings.

The following insiders have sold NRIX shares in the last 24 months: Gwenn Hansen ($914,573.14), Houte Hans Van ($1,128,708.22), and Julia P Gregory ($528,442.20).

Insiders have sold a total of 140,219 Nurix Therapeutics shares in the last 24 months for a total of $2,571,723.56 sold.



Insider trading data for NASDAQ:NRIX was last updated on 10/15/2026, the date of the most recent reported insider or congressional trade. New trades are added as they're reported.
From Our Partners